Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending July 31 2022

Healthcare Private Placement and M&A Transactions Review Week Ending July 31 2022

by Jonathan Hodson-Walker | Aug 2, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Vicinitas Therapeutics: The company raised $65 million of Series A venture funding in a deal led by Deerfield Management and Andreessen Horowitz on July 28, 2022. GV, The Mark Foundation for...
Healthcare Private Placement and M&A Transactions Review Week Ending July 24 2022

Healthcare Private Placement and M&A Transactions Review Week Ending July 24 2022

by Jonathan Hodson-Walker | Jul 26, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Centivo: The company raised $81 million of Series B1 venture funding in a deal led by Maverick Ventures and B Capital Group on July 18, 2022, putting the company’s pre-money valuation at...
Healthcare Private Placement and M&A Transactions Review Week Ending July 17 2022

Healthcare Private Placement and M&A Transactions Review Week Ending July 17 2022

by Jonathan Hodson-Walker | Jul 22, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Artio Medical: The company raised $28 million of Series A venture funding from undisclosed investors on July 16, 2022. The company is a developer of medical devices designed to develop...
Healthcare Private Placement and M&A Transactions Review Week Ending July 10 2022

Healthcare Private Placement and M&A Transactions Review Week Ending July 10 2022

by Jonathan Hodson-Walker | Jul 13, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions Immutics: The company raised $100 million of venture funding from undisclosed investors on July 6, 2022. The company is a developer of antibody drugs intended for applications in Immuno oncology...
Healthcare Private Placement and M&A Transactions Review Week Ending July 3 2022

Healthcare Private Placement and M&A Transactions Review Week Ending July 3 2022

by Jonathan Hodson-Walker | Jul 8, 2022 | Healthcare

Strategy | Financing Highlight Private Placement / Financing Transactions AmplifyBio: The company raised $100 million of venture funding from undisclosed investors on June 27, 2022. The company is an operator of a biotechnology platform intended to advance the quality...
Healthcare Private Placement and M&A Transactions Review Week Ending June 19 2022

Healthcare Private Placement and M&A Transactions Review Week Ending June 19 2022

by Jonathan Hodson-Walker | Jun 24, 2022 | Healthcare

Private Placement / Financing Transactions Ablative Solutions: The company raised $91.4 million through a combination of Series D1 and Series D2 venture funding in a deal led by BioStar Capital and Gilde Healthcare Partners on June 13, 2022, putting the...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives